Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Sherwin

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Journal of the National Cancer Institute|October 1, 1982
Transforming growth factors in the urine of normal, pregnant, and tumor-bearing humansD R Twardzik, S A Sherwin, J Ranchalis, et al.
Journal of Biological Response Modifiers|December 1, 1987
The absence of interferon antibody formation in patients receiving recombinant human interferon-gammaH S Jaffe, A B Chen, S Kramer, et al.
Cancer Research|September 1, 1981
Expression of epidermal and nerve growth factor receptors and soft agar growth factor production by human lung cancer cellsS A Sherwin, J D Minna, A F Gazdar, et al.
Cell|April 1, 1978
MAC-1, a new genetically transmitted type C virus of primates: "low frequency" activation from stumptail monkey cell culturesG J Todaro, R E Benveniste, S A Sherwin, et al.
Journal of Virology|May 1, 1978
Rescue of endogenous 30S retroviral sequences from mouse cells by baboon type C virusS A Sherwin, U R Rapp, R E Benveniste, et al.
Journal of Biological Response Modifiers|January 1, 1983
Effects of recombinant interferon-alpha on immune function in cancer patientsA E Maluish, R Leavitt, S A Sherwin, et al.
Biotechnology Therapeutics|January 1, 1989
A phase I/II study of recombinant tumor necrosis factor and recombinant interferon gamma in patients with AIDS-related complexL D Kaplan, D I Abrams, S A Sherwin, et al.
Cancer Treatment Reports|December 1, 1986
Phase I study of i.v. administered recombinant gamma interferon in cancer patientsR Kurzrock, J R Quesada, M G Rosenblum, et al.
Cancer Research|January 1, 1983
High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancerS A Sherwin, D R Twardzik, W H Bohn, et al.
Seminars in Oncology|December 1, 1982
Poorly differentiated lung cancerM F Fer, S A Sherwin, R K Oldham, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Journal of the National Cancer Institute|October 1, 1982
Transforming growth factors in the urine of normal, pregnant, and tumor-bearing humansD R Twardzik, S A Sherwin, J Ranchalis, et al.
Journal of Biological Response Modifiers|December 1, 1987
The absence of interferon antibody formation in patients receiving recombinant human interferon-gammaH S Jaffe, A B Chen, S Kramer, et al.
Cancer Research|September 1, 1981
Expression of epidermal and nerve growth factor receptors and soft agar growth factor production by human lung cancer cellsS A Sherwin, J D Minna, A F Gazdar, et al.
Cell|April 1, 1978
MAC-1, a new genetically transmitted type C virus of primates: "low frequency" activation from stumptail monkey cell culturesG J Todaro, R E Benveniste, S A Sherwin, et al.
Journal of Virology|May 1, 1978
Rescue of endogenous 30S retroviral sequences from mouse cells by baboon type C virusS A Sherwin, U R Rapp, R E Benveniste, et al.
Journal of Biological Response Modifiers|January 1, 1983
Effects of recombinant interferon-alpha on immune function in cancer patientsA E Maluish, R Leavitt, S A Sherwin, et al.
Biotechnology Therapeutics|January 1, 1989
A phase I/II study of recombinant tumor necrosis factor and recombinant interferon gamma in patients with AIDS-related complexL D Kaplan, D I Abrams, S A Sherwin, et al.
Cancer Treatment Reports|December 1, 1986
Phase I study of i.v. administered recombinant gamma interferon in cancer patientsR Kurzrock, J R Quesada, M G Rosenblum, et al.
Cancer Research|January 1, 1983
High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancerS A Sherwin, D R Twardzik, W H Bohn, et al.
Seminars in Oncology|December 1, 1982
Poorly differentiated lung cancerM F Fer, S A Sherwin, R K Oldham, et al.
Pageof 6